Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Tackle Zero Based Budgeting And Child Expenses with methods that allocate funds for loved ones without compromising long-term goals.
28,655 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Magnum Ice Cream’s public split from Unilever has turned Ben & Jerry’s into a governance flashpoint. The brand’s acti...
A high-stakes clash between Ray Dalio and Michael Saylor drives a renewed bitcoin price analysis as markets digest Bi...
A global CEO survey shows a shift away from junior roles as companies deploy AI. The move, echoed by Harvard findings...
A revived SpaceX IPO talk targets a multi‑trillion valuation, potentially lifting Elon Musk over $1 trillion in net w...
Billionaire Tom Steyer has shattered spending records with a $195 million political ad blitz this year, dwarfing riva...
As markets wobble toward summer, defensive bets like the Vanguard Consumer Staples Index ETF offer ballast. Learn why...
The Silver Miners ETF (SLVR) reversed a rapid rise with a sharp one-day decline, underscoring the risk built into lev...
With the MiCA grace period ending on July 1, 2026, thousands of platforms face closure or forced transfers. Millions ...
A retiree faces a pivotal choice between VIG and SCHD to anchor a $500,000 dividend strategy. The decision hinges on ...
The CLARITY Act moves to a July field hearing in New York, but final passage now hinges on seven Senate Democrats. An...
Adobe data shows Prime Day online spending near $26.4 billion, beating forecasts by a slim margin. The four-day event...